A new version 19.2 of the Human Protein Atlas released with information regarding human disease involvements...Read more

G protein-coupled receptors (GPCRs) are the most pharmaceutically exploited family of proteins, being the target for 34% of drugs. Although GPCRs also exist in as oligomeric forms, the only GPCR oligomers to be targeted by FDA-approved drugs act through GPCRs in complex with a receptor activity-modifying protein (RAMP), a family of three single transmembrane proteins...Read more

Andreas Hober joins HUPO's Early Career Researcher Initiative..Read more